Table 1.
Baseline characteristics stratified by sex.
| All (N = 1,316) | Women (N = 587) | Men (N = 729) | |
|---|---|---|---|
| Demographics | |||
| Age (years), mean (SD) | 72 (12) | 73 (11) | 71 (11) |
| <65 years, n (%) | 320 (24.3) | 111 (18.9) | 209 (28.7) |
| 65 to 74 years, n (%) | 376 (28.6) | 164 (27.9) | 212 (29.1) |
| ≥75 years, n (%) | 620 (47.1) | 312 (53.2) | 308 (42.2) |
| Marital status–married, n (%) | 941 (71.5) | 342 (58.3) | 599 (82.2) |
| Comorbidities | |||
| Hypertension, n (%) | 954 (72.5) | 441 (75.3) | 513 (70.4) |
| Diabetes, n (%) | 393 (29.9) | 170 (29.0) | 223 (30.6) |
| COPD, n (%) | 189 (14.4) | 80 (13.7) | 109 (15.0) |
| CAD, n (%) | 168 (12.8) | 57 (9.7) | 111 (15.2) |
| Atrial fibrillation, n (%) | 344 (26.2) | 203 (34.6) | 141 (19.3) |
| Anemia (hemoglobin <13 g/dL in men, <12 g/dL in women), n (%) | 465 (35.3) | 194 (33.1) | 271 (37.2) |
| Renal dysfunction (eGFR <60 mL/min/1.73 m2), n (%) | 233 (17.7) | 118 (20.1) | 115 (15.8) |
| Stroke-related characteristics | |||
| CMG 108, n (%) | 153 (11.6) | 75 (12.8) | 78 (10.7) |
| CMG 109, n (%) | 123 (9.3) | 51 (8.7) | 72 (9.9) |
| CMG 110, n (%) | 1,040 (79.0) | 461 (78.5) | 579 (79.4) |
| Time from stroke onset to rehabilitation admission (days), median (IQR) | 23.7 (16.6) | 23.2 (16.3) | 24.1 (16.9) |
| Time from stroke onset to rehabilitation admission ≤30 days, n (%) | 993 (75.5) | 449 (76.5) | 544 (74.6) |
| Ischemic stroke, n (%) | 1,051 (79.9) | 488 (83.1) | 563 (77.2) |
| Hemorrhagic stroke, n (%) | 265 (20.1) | 99 (16.9) | 166 (22.8) |
| Dysphagia, n (%) | 277 (21.0) | 120 (20.4) | 157 (21.5) |
| Neglect, n (%) | 187 (14.2) | 87 (14.8) | 100 (13.7) |
| Aphasia, n (%) | 581 (44.1) | 255 (43.4) | 326 (44.7) |
| Site of impairment | |||
| Right body, n (%) | 663 (50.4) | 291 (49.6) | 372 (51.0) |
| Left body, n (%) | 653 (49.5) | 296 (50.4) | 357 (49.0) |
| 12-item motor-FIM score at admission, mean (SD) | 17.4 (5.6) | 17.3 (5.6) | 17.4 (5.5) |
| Cognitive-FIM score at admission, mean (SD) | 16.7 (9.3) | 16.5 (9.3) | 16.8 (9.2) |
| Length of stay (days), mean (SD) | 54 (17) | 54 (16) | 54 (18) |
| Laboratory findings | |||
| Blood urea nitrogen (mg/dl), mean (SD) | 21 (11) | 20 (11) | 22 (10) |
| Serum creatinine (mg/dl), mean (SD) | 0.89 (0.35) | 0.79 (0.32) | 0.96 (0.36) |
| eGFR (mL/min/1.73 m2), mean (SD) | 83 (26) | 80 (25) | 86 (26) |
| Serum sodium (mmol/l), mean (SD) | 140.6 (4.1) | 141.0 (4.0) | 140.3 (4.1) |
| Serum sodium <135 mmol/l, n (%) | 56 (4.2) | 19 (3.2) | 37 (5.1) |
| Hemoglobin (g/dl), mean (SD) | 13.1 (1.8) | 12.6 (1.6) | 13.5 (1.8) |
| Total cholesterol (mg/dl), mean (SD) | 163 (43) | 176 (45) | 153 (39) |
N, denotes number; SD, standard deviation; COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; CMG, case-mix group; eGFR, estimated glomerular filtration rate.